PUMA
Istituto di Fisiologia Clinica     
Botto N., Andreassi M. G., Rizza A., Berti S., Bevilacqua S., Federici C., Palmieri C., Glauber M., Biagini A. C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization. In: International Journal of Cardiology, vol. 96 (3) pp. 341 - 345. Elsevier, 2004.
 
 
Abstract
(English)
Background: A common point mutation (C677T) in the gene for 5,10-methylenetetrahydrofolate reductase (MTHFR) is associated with hyperhomocysteinemia, an independent risk factor and a strong predictor of mortality in patients with coronary artery disease (CAD). The aim of this study was to investigate whether C677T polymorphism can be a predictor of major adverse cardiac events after myocardial revascularization. Methods: We determined MTHFR genotype in 159 patients with CAD undergoing myocardial revascularization [72 percutaneous transluminal coronary angioplasty (PTCA) and 87 coronary artery bypass graft (CABG)]. Recurrent angina, nonfatal myocardial infarction (MI), target vessel revascularization, heart failure and cardiac death were considered major adverse cardiac events that occurred after discharge from index hospitalization. Results: During the follow-up (6.9F0.3 months, meanFS.E.M.), the composite endpoint accounted for 25.9%, 11.4% and 4.3% for TT, CT and CC genotype (log-rank statistic 5.2, p = 0.02), respectively. Subjects with mutant TT genotype had a threefold increase of any cardiac event (hazard ratio [HR] = 3.0; 95% [CI], 1.1-8.1). In multiple-variable regression Cox, predictors of events were TT genotype (HR = 2.8; 95% CI, 1.01-7.62, p = 0.047), low-ejection fraction < 40% (HR = 4.5; 95% CI, 1.62-12.6, p = 0.004) and revascularization procedure (HR = 6.1; 95% CI, 1.86-20.34, p = 0.003). Conclusions: These data indicate that the TT genotype seems to be significantly associated with major adverse cardiac events after myocardial revascularization in CAD patients, suggesting a potential pathological influence of homocysteine in the clinical outcome.
URL: http://scienceserver.cilea.it/pdflinks/07021217595614507.pdf
Subject Coronary artery disease


Icona documento 1) Download Document PDF


Icona documento Open access Icona documento Restricted Icona documento Private

 


Per ulteriori informazioni, contattare: Librarian http://puma.isti.cnr.it

Valid HTML 4.0 Transitional